<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#Cover" roleURI="http://maiuspharma.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#InterimBalanceSheet" roleURI="http://maiuspharma.com/role/InterimBalanceSheet" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#InterimBalanceSheetParenthetical" roleURI="http://maiuspharma.com/role/InterimBalanceSheetParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#InterimStatementOfOperationsAndComprehensiveLoss" roleURI="http://maiuspharma.com/role/InterimStatementOfOperationsAndComprehensiveLoss" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#InterimStatementOfChangesInShareholdersDeficit" roleURI="http://maiuspharma.com/role/InterimStatementOfChangesInShareholdersDeficit" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#InterimStatementOfCashFlows" roleURI="http://maiuspharma.com/role/InterimStatementOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#OrganizationAndBusinessDescription" roleURI="http://maiuspharma.com/role/OrganizationAndBusinessDescription" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://maiuspharma.com/role/SummaryOfSignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#PrepaymentsAndOtherAssets" roleURI="http://maiuspharma.com/role/PrepaymentsAndOtherAssets" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#DeferredIpoCosts" roleURI="http://maiuspharma.com/role/DeferredIpoCosts" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#AmountsDueFromRelatedParties" roleURI="http://maiuspharma.com/role/AmountsDueFromRelatedParties" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#PropertyPlantAndEquipmentNet" roleURI="http://maiuspharma.com/role/PropertyPlantAndEquipmentNet" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#Leases" roleURI="http://maiuspharma.com/role/Leases" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#RelatedPartyTransactions" roleURI="http://maiuspharma.com/role/RelatedPartyTransactions" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#AccountsPayable" roleURI="http://maiuspharma.com/role/AccountsPayable" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#AmountsDueToRelatedParties" roleURI="http://maiuspharma.com/role/AmountsDueToRelatedParties" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#Equity" roleURI="http://maiuspharma.com/role/Equity" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#IncomeTaxes" roleURI="http://maiuspharma.com/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#CapitalCommitment" roleURI="http://maiuspharma.com/role/CapitalCommitment" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#SubsequentEvents" roleURI="http://maiuspharma.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#UnauditedProFormaFinancialInformation" roleURI="http://maiuspharma.com/role/UnauditedProFormaFinancialInformation" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ConvertibleBonds" roleURI="http://maiuspharma.com/role/ConvertibleBonds" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#InitialPublicOffering" roleURI="http://maiuspharma.com/role/InitialPublicOffering" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#PrivatePlacement" roleURI="http://maiuspharma.com/role/PrivatePlacement" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#FairValueMeasurements" roleURI="http://maiuspharma.com/role/FairValueMeasurements" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#CommitmentsAndContingencies" roleURI="http://maiuspharma.com/role/CommitmentsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#SegmentInformation" roleURI="http://maiuspharma.com/role/SegmentInformation" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#PromissoryNote" roleURI="http://maiuspharma.com/role/PromissoryNote" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://maiuspharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#OrganizationAndBusinessDescriptionTables" roleURI="http://maiuspharma.com/role/OrganizationAndBusinessDescriptionTables" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://maiuspharma.com/role/SummaryOfSignificantAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#PrepaymentsAndOtherAssetsTables" roleURI="http://maiuspharma.com/role/PrepaymentsAndOtherAssetsTables" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#DeferredIpoCostsTables" roleURI="http://maiuspharma.com/role/DeferredIpoCostsTables" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#AmountsDueFromRelatedPartiesTables" roleURI="http://maiuspharma.com/role/AmountsDueFromRelatedPartiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#PropertyPlantAndEquipmentNetTables" roleURI="http://maiuspharma.com/role/PropertyPlantAndEquipmentNetTables" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#LeasesTables" roleURI="http://maiuspharma.com/role/LeasesTables" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#RelatedPartyTransactionsTables" roleURI="http://maiuspharma.com/role/RelatedPartyTransactionsTables" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#AmountsDueToRelatedPartiesTables" roleURI="http://maiuspharma.com/role/AmountsDueToRelatedPartiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#UnauditedProFormaFinancialInformationTables" roleURI="http://maiuspharma.com/role/UnauditedProFormaFinancialInformationTables" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ConvertibleBondsTables" roleURI="http://maiuspharma.com/role/ConvertibleBondsTables" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#FairValueMeasurementsTables" roleURI="http://maiuspharma.com/role/FairValueMeasurementsTables" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfCompanyAndSubsidiariesDetails" roleURI="http://maiuspharma.com/role/ScheduleOfCompanyAndSubsidiariesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#OrganizationAndBusinessDescriptionDetailsNarrative" roleURI="http://maiuspharma.com/role/OrganizationAndBusinessDescriptionDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfTranslationOfAmountAtExchangeRatesDetails" roleURI="http://maiuspharma.com/role/ScheduleOfTranslationOfAmountAtExchangeRatesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfEstimatedLivesOfPropertyPlantAndEquipmentDetails" roleURI="http://maiuspharma.com/role/ScheduleOfEstimatedLivesOfPropertyPlantAndEquipmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" roleURI="http://maiuspharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfPrepaymentAndOtherAssetsDetails" roleURI="http://maiuspharma.com/role/ScheduleOfPrepaymentAndOtherAssetsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfDeferredIpoCostsDetails" roleURI="http://maiuspharma.com/role/ScheduleOfDeferredIpoCostsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfAmountDueFromRelatedPartiesDetails" roleURI="http://maiuspharma.com/role/ScheduleOfAmountDueFromRelatedPartiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfPropertyPlantAndEquipmentNetDetails" roleURI="http://maiuspharma.com/role/ScheduleOfPropertyPlantAndEquipmentNetDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#PropertyPlantAndEquipmentNetDetailsNarrative" roleURI="http://maiuspharma.com/role/PropertyPlantAndEquipmentNetDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfSupplementalBalanceSheetInformationForLeasesDetails" roleURI="http://maiuspharma.com/role/ScheduleOfSupplementalBalanceSheetInformationForLeasesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfUndiscountedFutureMinimumLeasePaymentDetails" roleURI="http://maiuspharma.com/role/ScheduleOfUndiscountedFutureMinimumLeasePaymentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#LeasesDetailsNarrative" roleURI="http://maiuspharma.com/role/LeasesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfSignificantRelatedPartyTransactionsDetails" roleURI="http://maiuspharma.com/role/ScheduleOfSignificantRelatedPartyTransactionsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfAmountsDueToRelatedPartiesDetails" roleURI="http://maiuspharma.com/role/ScheduleOfAmountsDueToRelatedPartiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#EquityDetailsNarrative" roleURI="http://maiuspharma.com/role/EquityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#IncomeTaxesDetailsNarrative" roleURI="http://maiuspharma.com/role/IncomeTaxesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#CapitalCommitmentDetailsNarrative" roleURI="http://maiuspharma.com/role/CapitalCommitmentDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#SubsequentEventsDetailsNarrative" roleURI="http://maiuspharma.com/role/SubsequentEventsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfUnauditedProFormaFinancialInformationDetails" roleURI="http://maiuspharma.com/role/ScheduleOfUnauditedProFormaFinancialInformationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfConvertibleBondsDetails" roleURI="http://maiuspharma.com/role/ScheduleOfConvertibleBondsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfNetIncomePerShareDetails" roleURI="http://maiuspharma.com/role/ScheduleOfNetIncomePerShareDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ConvertibleBondsDetailsNarrative" roleURI="http://maiuspharma.com/role/ConvertibleBondsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#InitialPublicOfferingDetailsNarrative" roleURI="http://maiuspharma.com/role/InitialPublicOfferingDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#PrivatePlacementDetailsNarrative" roleURI="http://maiuspharma.com/role/PrivatePlacementDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" roleURI="http://maiuspharma.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#CommitmentsAndContingenciesDetailsNarrative" roleURI="http://maiuspharma.com/role/CommitmentsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="mpgc-20250531.xsd#PromissoryNoteDetailsNarrative" roleURI="http://maiuspharma.com/role/PromissoryNoteDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/InterimBalanceSheet" xlink:title="00000002 - Statement - Interim Balance Sheet">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapEscrowDeposit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaapDeferredCosts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapDeferredCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNotesPayableCurrent" xlink:label="loc_us-gaapOtherNotesPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuredDebtCurrent" xlink:label="loc_us-gaapSecuredDebtCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapSecuredDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleSubordinatedDebtCurrent" xlink:label="loc_us-gaapConvertibleSubordinatedDebtCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleSubordinatedDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityClassifiedNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mpgc-20250531.xsd#MPGC_SubscriptionReceivables" xlink:label="loc_MPGCSubscriptionReceivables" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_MPGCSubscriptionReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/InterimBalanceSheetParenthetical" xlink:title="00000003 - Statement - Interim Balance Sheet (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/InterimStatementOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Interim Statement of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaapOtherNoncashIncomeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNoncashIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeDividend" xlink:label="loc_us-gaapInvestmentIncomeDividend" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeDividend" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaapInterestIncomeOther" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/InterimStatementOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Interim Statement of Changes in Shareholders&apos; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/InterimStatementOfCashFlows" xlink:title="00000006 - Statement - Interim Statement of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeDividend" xlink:label="loc_us-gaapInvestmentIncomeDividend" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInvestmentIncomeDividend" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAssetAmortization" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueFromRelatedPartiesCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="mpgc-20250531.xsd#MPGC_IncreaseDecreaseInRightOfUseAssetsNet" xlink:label="loc_MPGCIncreaseDecreaseInRightOfUseAssetsNet" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_MPGCIncreaseDecreaseInRightOfUseAssetsNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mpgc-20250531.xsd#MPGC_IncreaseDecreaseInValueAddedTaxVatAndOtherTaxPayable" xlink:label="loc_MPGCIncreaseDecreaseInValueAddedTaxVatAndOtherTaxPayable" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_MPGCIncreaseDecreaseInValueAddedTaxVatAndOtherTaxPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mpgc-20250531.xsd#MPGC_IncreaseDecreaseInConvertibleBonds" xlink:label="loc_MPGCIncreaseDecreaseInConvertibleBonds" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_MPGCIncreaseDecreaseInConvertibleBonds" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mpgc-20250531.xsd#MPGC_IncreaseDecreaseInRightOfUseLiabilities" xlink:label="loc_MPGCIncreaseDecreaseInRightOfUseLiabilities" />
      <link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_MPGCIncreaseDecreaseInRightOfUseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="mpgc-20250531.xsd#MPGC_ProceedsFromRepaymentsOfSaleOfShortTermInvestments" xlink:label="loc_MPGCProceedsFromRepaymentsOfSaleOfShortTermInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_MPGCProceedsFromRepaymentsOfSaleOfShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="mpgc-20250531.xsd#MPGC_ExtensionPaymentsDepositedInTrustAccount" xlink:label="loc_MPGCExtensionPaymentsDepositedInTrustAccount" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_MPGCExtensionPaymentsDepositedInTrustAccount" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleAndCollectionOfReceivables" xlink:label="loc_us-gaapProceedsFromSaleAndCollectionOfReceivables" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleAndCollectionOfReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForProceedsFromOtherDeposits" xlink:label="loc_us-gaapPaymentsForProceedsFromOtherDeposits" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromOtherDeposits" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaapProceedsFromContributionsFromAffiliates" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromContributionsFromAffiliates" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering" xlink:label="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfInitialPublicOffering" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaapPaymentsOfDividendsCommonStock" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromOtherDebt" xlink:label="loc_us-gaapProceedsFromOtherDebt" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromOtherDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/OrganizationAndBusinessDescription" xlink:title="999007 - Disclosure - ORGANIZATION AND BUSINESS DESCRIPTION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999008 - Disclosure - SUMMARY OF THE SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/PrepaymentsAndOtherAssets" xlink:title="999009 - Disclosure - PREPAYMENTS AND OTHER ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/DeferredIpoCosts" xlink:title="999010 - Disclosure - DEFERRED IPO COSTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/AmountsDueFromRelatedParties" xlink:title="999011 - Disclosure - AMOUNTS DUE FROM RELATED PARTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/PropertyPlantAndEquipmentNet" xlink:title="999012 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/Leases" xlink:title="999013 - Disclosure - LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/RelatedPartyTransactions" xlink:title="999014 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/AccountsPayable" xlink:title="999015 - Disclosure - ACCOUNTS PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/AmountsDueToRelatedParties" xlink:title="999016 - Disclosure - AMOUNTS DUE TO RELATED PARTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/Equity" xlink:title="999017 - Disclosure - EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/IncomeTaxes" xlink:title="999018 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/CapitalCommitment" xlink:title="999019 - Disclosure - CAPITAL COMMITMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/SubsequentEvents" xlink:title="999020 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/UnauditedProFormaFinancialInformation" xlink:title="999021 - Disclosure - UNAUDITED PRO FORMA FINANCIAL INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ConvertibleBonds" xlink:title="999022 - Disclosure - CONVERTIBLE BONDS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/InitialPublicOffering" xlink:title="999023 - Disclosure - INITIAL PUBLIC OFFERING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/PrivatePlacement" xlink:title="999024 - Disclosure - PRIVATE PLACEMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/FairValueMeasurements" xlink:title="999025 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/CommitmentsAndContingencies" xlink:title="999026 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/SegmentInformation" xlink:title="999027 - Disclosure - SEGMENT INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/PromissoryNote" xlink:title="999028 - Disclosure - PROMISSORY NOTE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999029 - Disclosure - SUMMARY OF THE SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/OrganizationAndBusinessDescriptionTables" xlink:title="999030 - Disclosure - ORGANIZATION AND BUSINESS DESCRIPTION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999031 - Disclosure - SUMMARY OF THE SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/PrepaymentsAndOtherAssetsTables" xlink:title="999032 - Disclosure - PREPAYMENTS AND OTHER ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/DeferredIpoCostsTables" xlink:title="999033 - Disclosure - DEFERRED IPO COSTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/AmountsDueFromRelatedPartiesTables" xlink:title="999034 - Disclosure - AMOUNTS DUE FROM RELATED PARTIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/PropertyPlantAndEquipmentNetTables" xlink:title="999035 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/LeasesTables" xlink:title="999036 - Disclosure - LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/RelatedPartyTransactionsTables" xlink:title="999037 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/AmountsDueToRelatedPartiesTables" xlink:title="999038 - Disclosure - AMOUNTS DUE TO RELATED PARTIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/UnauditedProFormaFinancialInformationTables" xlink:title="999039 - Disclosure - UNAUDITED PRO FORMA FINANCIAL INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ConvertibleBondsTables" xlink:title="999040 - Disclosure - CONVERTIBLE BONDS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/FairValueMeasurementsTables" xlink:title="999041 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfCompanyAndSubsidiariesDetails" xlink:title="999042 - Disclosure - SCHEDULE OF COMPANY AND SUBSIDIARIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/OrganizationAndBusinessDescriptionDetailsNarrative" xlink:title="999043 - Disclosure - ORGANIZATION AND BUSINESS DESCRIPTION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfTranslationOfAmountAtExchangeRatesDetails" xlink:title="999044 - Disclosure - SCHEDULE OF TRANSLATION OF AMOUNT AT EXCHANGE RATES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfEstimatedLivesOfPropertyPlantAndEquipmentDetails" xlink:title="999045 - Disclosure - SCHEDULE OF ESTIMATED LIVES OF PROPERTY, PLANT AND EQUIPMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999046 - Disclosure - SUMMARY OF THE SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfPrepaymentAndOtherAssetsDetails" xlink:title="999047 - Disclosure - SCHEDULE OF PREPAYMENT AND OTHER ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="mpgc-20250531.xsd#MPGC_PrepaidDeposits" xlink:label="loc_MPGCPrepaidDeposits" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_MPGCPrepaidDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mpgc-20250531.xsd#MPGC_EmployeePettyCash" xlink:label="loc_MPGCEmployeePettyCash" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_MPGCEmployeePettyCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Supplies" xlink:label="loc_us-gaapSupplies" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapSupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mpgc-20250531.xsd#MPGC_ChemicalSynthesisCosts" xlink:label="loc_MPGCChemicalSynthesisCosts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_MPGCChemicalSynthesisCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaapPrepaidTaxes" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapPrepaidTaxes" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfDeferredIpoCostsDetails" xlink:title="999048 - Disclosure - SCHEDULE OF DEFERRED IPO COSTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaapDeferredCosts" />
      <link:loc xlink:type="locator" xlink:href="mpgc-20250531.xsd#MPGC_DeferredCostsLegalFees" xlink:label="loc_MPGCDeferredCostsLegalFees" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredCosts" xlink:to="loc_MPGCDeferredCostsLegalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="mpgc-20250531.xsd#MPGC_DeferredCostsAuditFees" xlink:label="loc_MPGCDeferredCostsAuditFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredCosts" xlink:to="loc_MPGCDeferredCostsAuditFees" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfAmountDueFromRelatedPartiesDetails" xlink:title="999049 - Disclosure - SCHEDULE OF AMOUNT DUE FROM RELATED PARTIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfPropertyPlantAndEquipmentNetDetails" xlink:title="999050 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/PropertyPlantAndEquipmentNetDetailsNarrative" xlink:title="999051 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfSupplementalBalanceSheetInformationForLeasesDetails" xlink:title="999052 - Disclosure - SCHEDULE OF SUPPLEMENTAL BALANCE SHEET INFORMATION FOR LEASES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfUndiscountedFutureMinimumLeasePaymentDetails" xlink:title="999053 - Disclosure - SCHEDULE OF UNDISCOUNTED FUTURE MINIMUM LEASE PAYMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/LeasesDetailsNarrative" xlink:title="999054 - Disclosure - LEASES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfSignificantRelatedPartyTransactionsDetails" xlink:title="999055 - Disclosure - SCHEDULE OF SIGNIFICANT RELATED PARTY TRANSACTIONS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfAmountsDueToRelatedPartiesDetails" xlink:title="999056 - Disclosure - SCHEDULE OF AMOUNTS DUE TO RELATED PARTIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/EquityDetailsNarrative" xlink:title="999057 - Disclosure - EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/IncomeTaxesDetailsNarrative" xlink:title="999058 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/CapitalCommitmentDetailsNarrative" xlink:title="999059 - Disclosure - CAPITAL COMMITMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/SubsequentEventsDetailsNarrative" xlink:title="999060 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfUnauditedProFormaFinancialInformationDetails" xlink:title="999061 - Disclosure - SCHEDULE OF UNAUDITED PRO FORMA FINANCIAL INFORMATION (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfConvertibleBondsDetails" xlink:title="999062 - Disclosure - SCHEDULE OF CONVERTIBLE BONDS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfNetIncomePerShareDetails" xlink:title="999063 - Disclosure - SCHEDULE OF NET INCOME PER SHARE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ConvertibleBondsDetailsNarrative" xlink:title="999064 - Disclosure - CONVERTIBLE BONDS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/InitialPublicOfferingDetailsNarrative" xlink:title="999065 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/PrivatePlacementDetailsNarrative" xlink:title="999066 - Disclosure - PRIVATE PLACEMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="999067 - Disclosure - SCHEDULE OF ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999068 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://maiuspharma.com/role/PromissoryNoteDetailsNarrative" xlink:title="999069 - Disclosure - PROMISSORY NOTE (Details Narrative)" />
</link:linkbase>
